In contrast to the widely studied solid tumors, not many studies have examined the role of IGF-IR in hematological neoplasms, and most of these studies focused on plasma cell myeloma [54, 55]. This evidence concerns the gene IGF1R and hematopoietic and lymphoid system neoplasm.